Washington is the latest state to file litigation against Johnson & Johnson (JNJ -0.4%) over its role in the opioid crisis there.
A trial in New York is set to begin in March although many observers expect a settlement beforehand.
The company also one of the targets in a federal probe to determine if it violated the Controlled Substances Act.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.